Guangzhou Bioresette Biomedical

Guangzhou Bioresette Biomedical is a life sciences technology company focused on the development of high-throughput single-cell sequencing systems and microfluidic solutions. The company provides an integrated platform that includes automated instruments, specialized microfluidic chips, and bioinformatics software designed for large-scale single-cell analysis. Their flagship products, such as the BR-100 Single Cell System, utilize droplet-based technology to enable researchers to perform transcriptome and proteome profiling at the individual cell level. Bioresette's technology is primarily applied in oncology research, immunology, and precision medicine to uncover cellular heterogeneity. The company aims to provide cost-effective and efficient tools to accelerate biological discovery and clinical diagnostics.